Cipher Pharmaceuticals Inc.
CPHRF
Price:
$10.65
Market Cap:
$272.52M
Cipher Pharmaceuticals Inc. operates as a specialty pharmaceutical company in Canada. Its commercial products include Epuris (CIP-ISOTRETINOIN), a formulation of the active ingredient isotretinoin for use in the treatment of severe acne; Ozenoxacin to treat adult and paediatric patients with impetigo; Actikerall, which is indicated for the treatment of palpable or moderately thick hyperkeratotic actinic keratosis; Vaniqa, a prescription cream that reduces the growth of unwanted facial hair in women; BRINAVESS, a treatment for sinus rhythm in adults; and AGGRASTAT, an intravenous anti-platelet drug. The company's licensed products comprise CIP-Isotretinoin; Lipofen (CIP-Fenofibrate), a formul...[Read more]
Industry
Drug Manufacturers - Specialty & Generic
IPO Date
2006-02-02
Stock Exchange
PNK
Ticker
CPHRF
The Enterprise Value as of September 2024 (TTM) for Cipher Pharmaceuticals Inc. (CPHRF) is 224.84M
According to Cipher Pharmaceuticals Inc.’s latest financial reports and current stock price. The company's current Enterprise Value is 224.84M. This represents a change of 199.97% compared to the average of 74.95M of the last 4 quarters.
Cipher Pharmaceuticals Inc. (CPHRF) Historical Enterprise Value (quarterly & annually)
How has CPHRF Enterprise Value performed in the past?
The mean historical Enterprise Value of Cipher Pharmaceuticals Inc. over the last ten years is 86.18M. The current 224.84M Enterprise Value has changed 25.99% with respect to the historical average. Over the past ten years (40 quarters), CPHRF's Enterprise Value was at its highest in in the December 2014 quarter at 313.85M. The Enterprise Value was at its lowest in in the December 2020 quarter at -7270185.36.
Average
86.18M
Median
54.01M
Minimum
12.17M
Maximum
359.14M
Cipher Pharmaceuticals Inc. (CPHRF) Enterprise Value by Quarter and Year
Discovering the peaks and valleys of Cipher Pharmaceuticals Inc. Enterprise Value, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 143.35%
Maximum Annual Enterprise Value = 359.14M
Minimum Annual Increase = -64.13%
Minimum Annual Enterprise Value = 12.17M
| Year | Enterprise Value | Change |
|---|---|---|
| 2023 | 65.50M | 54.06% |
| 2022 | 42.52M | 143.35% |
| 2021 | 17.47M | 43.62% |
| 2020 | 12.17M | -57.66% |
| 2019 | 28.73M | -29.84% |
| 2018 | 40.95M | -52.57% |
| 2017 | 86.34M | 7.62% |
| 2016 | 80.22M | -37.72% |
| 2015 | 128.81M | -64.13% |
| 2014 | 359.14M | 127.59% |
Cipher Pharmaceuticals Inc. (CPHRF) Average Enterprise Value
How has CPHRF Enterprise Value performed in the past?
The current Enterprise Value of Cipher Pharmaceuticals Inc. (CPHRF) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages
3-year avg
41.83M
5-year avg
33.28M
10-year avg
86.18M
Cipher Pharmaceuticals Inc. (CPHRF) Enterprise Value vs. Peers
How is CPHRF’s Enterprise Value compared to its peers?
Cipher Pharmaceuticals Inc.’s Enterprise Value is greater than Bionoid Pharma Inc. (9.90M), greater than CENTR Brands Corp. (870.65K), greater than CTT Pharmaceutical Holdings, Inc. (1.46M), greater than Alterola Biotech, Inc. (11.76M), greater than Crescita Therapeutics Inc. (-7422748.57), greater than Cannara Biotech Inc. (114.38M), less than Knight Therapeutics Inc. (620.68M), greater than Lowell Farms Inc. (18.33M), greater than Aion Therapeutic Inc. (5.49M), greater than HLS Therapeutics Inc. (124.94M), greater than Canntab Therapeutics Limited (1.35M),
| Company | Enterprise Value | Market cap |
|---|---|---|
| 9.90M | $9.75M | |
| 870.65K | $880.06K | |
| 1.46M | $1.45M | |
| 11.76M | $10.22M | |
| -7422748.57 | $407.02K | |
| 114.38M | $52.21M | |
| 620.68M | $458.61M | |
| 18.33M | $199.65K | |
| 5.49M | $2.80M | |
| 124.94M | $74.40M | |
| 1.35M | $147.02K |
Build a custom stock screener for Cipher Pharmaceuticals Inc. (CPHRF) and other stocks
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Cipher Pharmaceuticals Inc. using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
Cipher Pharmaceuticals Inc. (CPHRF) and other stocks custom spreadsheet templates
The easiest way to analyze a company like Cipher Pharmaceuticals Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
Frequently asked questions❓
What is the Enterprise Value?
How can you use the Enterprise Value?
What is Cipher Pharmaceuticals Inc.'s Enterprise Value?
What is the highest Enterprise Value for Cipher Pharmaceuticals Inc. (CPHRF)?
What is the 3-year average Enterprise Value for Cipher Pharmaceuticals Inc. (CPHRF)?
What is the 5-year average Enterprise Value for Cipher Pharmaceuticals Inc. (CPHRF)?
How does the current Enterprise Value for Cipher Pharmaceuticals Inc. (CPHRF) compare to its historical average?